Managing Cardiovascular Therapies in the Critically Ill

• Series Overview
• Program Content
• Faculty
• Target Audience and Learning Objectives
• Continuing Pharmacy Education Credit
• BCCCP Specialty Recertification Credit
• Technical Requirements
• Commercial Support
• Fees

Clinical Reasoning Series in Critical Care Pharmacy has been approved by the Board of Pharmacy Specialties for recertification of Board Certified Critical Care Pharmacy Specialists (BCCCPs).

BCCCPs are involved in managing cardiovascular related medication therapies. They are often responsible for assessing and developing drug therapy regimens for critically ill patients with acute cardiovascular related complications or supportive devices. Acute heart failure, thrombosis, bleeding and increasing application of devices have become common challenges in the intensive care unit. Critically ill patients with notable cardiovascular conditions are at high risk for organ related complications, adverse medication events and related morbidity and mortality that in many cases can be avoided. As our understanding of more optimal approaches to assessment tools and how to approach disease state management evolves, BCCCPs need to engage as prospective as possible using evidence-based strategies that frequently have to be individualized to the complexity and frequently understudied critically ill patient. The complexity of managing these conditions and common occurrences of special populations, this program will address current evidence-based strategies and summarize their place in contemporary patient care. The program will consist of several educational activities and include practice skills, current evidence and management approaches.

Release date: November 25, 2019
ORIGINAL BCCCP credit expiration date: May 15, 2020
EXTENDED BCCCP credit expiration date: July 10, 2020
ACPE credit expiration date: November 14, 2022

Topics to be covered include acute heart failure and related support strategies, atrial fibrillation, thrombosis management, coagulopathies, hemorrhagic emergencies and anticoagulation reversal. Each activity will discuss treatment strategies and application of skills to knowledge in developing management plans.

	William E. Dager, Pharm.D., FCCP, BCPS Pharmacist Specialist, Department of Pharmaceutical Services University of California Davis Medical Center Sacramento, California
	Christopher Michaud, Pharm.D., BCCCP, BCPS Clinical Pharmacy Specialist, Cardiothoracic ICU Spectrum Care Grand Rapids, Michigan
	Craig J. Beavers, Pharm.D., FAHA, BCPS-AQ Cardiology, AACC, CACP Director of Cardiovascular Services Baptist Health Paducah Cardiovascular Clinical Pharmacist University of Kentucky HealthCare Lexington, Kentucky Assistant Adjunct Professor University of Kentucky College of Pharmacy Lexington, Kentucky
	Alana M. Ciolek, Pharm.D. Cardiothoracic Intensive Care Clinical Pharmacy Specialist New York-Presbyterian Hospital New York, New York
	Eric W. Mueller, Pharm.D., FCCM, FCCP Assistant Director of Clinical Pharmacy Services and Research University of Cincinnati Medical Center Cincinnati, Ohio Adjunct Associate Professor of Pharmacy Practice and Administrative Sciences University of Cincinnati Cincinnati, Ohio

Clinical Pharmacists, and BCCCPs providing care to patients with acute heart failure and related support strategies, atrial fibrillation, thrombosis management, coagulopathies, hemorrhagic emergencies and anticoagulation reversal.

At the conclusion of Part 1 of the program, the participant should be able to:

• Describe skills to consider in initiating individualized pharmacotherapy
• Describe the risk assessment and initiating a antithrombotic prophylaxis or treatment management plan
• Describe when and how to approach the pharmacologic management of Atrial Fibrillation
• Explain the process of evaluating and initiating Thrombolytic therapy (non-Stroke setting)
• Describe the impact of unique patient characteristics that may lead to modified management plans in the setting of going into and out of acute Heart Failure
• Identify pharmacologic agents used in the acute management and impact of acute failure on other therapies
• Describe considerations for individualizing therapy in special populations

At the conclusion of Part 2 of the program, the participant should be able to:

• Describe skills that can be utilized to measure and adapt therapy to meet management goals
• Describe selected coagulopathic situations including liver failure and HIT
• Identify various agents used to reverse the effects of anticoagulants and antiplatelet agents
• Explain how anticoagulants and Antiplatelet agents are managed around invasive procedures
• Describe considerations for managing thrombosis and bleeding in patients with a LVAD/Impella or cardiac valve
• Explain the ECLS circuit and pharmacologic management considerations

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Managing Cardiovascular Therapies in the Critically Ill Part 1

Managing Cardiovascular Therapies in the Critically Ill Part 2

Methods and CE Requirements

ACPE Continuing Pharmacy Education Credit
To be eligible to earn ACPE continuing pharmacy education (CPE) credit, participants must purchase and successfully complete the course, and submit and pass the Web-based posttest(s) by November 14, 2022. Partial credit is not available for this activity. Posttests may not be submitted more than one time.

National Association of Boards of Pharmacy - CPE Monitor Service

Provided through the collaborative efforts of the National Association of Boards of Pharmacy (NABP), the Accreditation Council for Pharmacy Education (ACPE), and ACPE-accredited providers, the CPE Monitor Service allows you to electronically keep track of continuing pharmacy education (CPE) credits from ACPE-accredited providers. ACPE-accredited providers, like ACCP, are responsible for transmitting this information to NABP to be stored in the CPE Monitor system. Statements of credit will be available at CPE Monitor, nabp.pharmacy/cpe-monitor-service/, within 2–3 business days after completion of this activity. For more information on CPE Monitor please visit nabp.pharmacy/cpe-monitor-service/.

To transfer these credits to CPE Monitor on your behalf your NABP e-Profile ID Number and date of birth must be listed on your ACCP account. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.

Some international pharmacists do not use the CPE Monitor service. To verify or update this information in your ACCP account, visit Licensure/Certification. Check the box “I am an international pharmacist or I am not licensed to practice in the United States, and do not have an NABP e-Profile ID.” Be sure to save your changes at the bottom of the page.

To be eligible to earn recertification credit, BCCCPs must purchase the recertification version of this course, successfully complete the course, and submit and pass the web-based posttest associated with each module by July 10, 2020. Partial credit is not available for this activity. Posttests may not be submitted more than one time.

The passing point to earn BCCCP recertification credit is based on an expert analysis of the assessment items in each posttest module. Any posttest submitted before the BCCCP posttest deadline that meets this passing point will earn BCCCP recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.

All participants must have a Board of Pharmacy Specialties (BPS) board certification credential number, BPS ID Number, and a BPS expiration date on file with ACCP for reporting purposes. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.

Questions regarding the number of hours required for BCCCP recertification should be directed to BPS at (202) 429-7591 or www.bpsweb.org. The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs.

Requires an Internet browser and Adobe Reader.

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.